 |
 |
GastroenterologyStomach & duodenum |
|
Click a heading in the right-hand column to see the selected systematic reviews in that subject area 
|
|
|
Please send any information about new or relevant Systematic Reviews to Evidence@GastroHep.com |
|
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline
Earle CC, Maroun J, Zuraw L; Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group Can J Surg 2002; 45(6): 438-46  |
|
|
|
|
Recent advance in gastric cancer chemotherapy.
[Article in Japanese]
Kubota T Gan To Kagaku Ryoho 2000; Nov;27(13): 2043-7 |
|
|
|
|
Docetaxel in advanced gastric cancer--review of the main clinical trials
Di Cosimo S, Ferretti G, Fazio N, Silvestris N, Carlini P, Alimonti A, Gelibter A, Felici A, Papaldo P, Cognetti F Acta Oncol 2003; 42(7): 693-700  |
|
|
|
|
Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis
Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC J Natl Cancer Inst 2003; 95(23): 1784-91 |
|
|
|
|
[Current status and future perspectives on chemotherapy in patients with gastric cancer: can the clinical data from Japan lead to a standard international therapy?]
[Article in Japanese]
Kim R, Yoshida K, Toge T Nippon Geka Gakkai Zasshi 2001; 102(10): 770-7 |
|
|
|
|
Gastric cancer treatment: a systematic review
Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S Oncol Rep 2004; 11(4): 911-6 |
|
|
|
|
Techniques of reconstruction after total gastrectomy for cancer
Lehnert T, Buhl K Br J Surg 2004; 91(5): 528-39 |
|
|
|
|
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I. Lancet 2004; 364(9440): 1127-34 |
|
|
|
|
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P, Nita M, Kazi H, Gama-Rodrigues J. Cochrane Database Syst Rev 2004; 18(4): CD001964 |
|
|
|
|
[Chemotherapy for gastric cancer] [Article in Japanese]
Baba H, Kakeji Y, Oki E, Tokunaga E, Ushiro S, Watanabe M, Maehara Y Gan To Kagaku Ryoho 2003; 30(12): 1881-8 |
|
|
|
|
Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
Sakamoto J, Morita S, Kodera Y, Rahman M, Nakao A. Cancer Chemother Pharmacol 2004; 54(1): S25-31 |
|
|
|
|
Quality of life in gastric cancer
Kaptein AA, Morita S, Sakamoto J World J Gastroenterol 2005; 11(21): 3189-96 |
|
|
|
|
Recent advances in multimodal treatment for gastric cancer: a review
Lordick F, Siewert JR Gastric Cancer 2005; 8(2): 78-85 |
|
|
|
|
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D Health Technol Assess 2005; 9(25): 1-142 |
|
|
|
|
The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer
Meyer HJ Eur J Surg Oncol 2005; 31(6): 595-604 |
|
|
|
|
| Archive:
1
2
3
4
|
Email this page to a colleague
